Login / Signup

Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy.

Rihito AizawaKenji TakayamaKiyonao NakamuraTakahiro InoueToshinari YamasakiTakashi KobayashiShusuke AkamatsuOsamu OgawaTakashi Mizowaki
Published in: International journal of clinical oncology (2019)
IMRT at a dose up to 78 Gy combined with short-term neoadjuvant ADT resulted in excellent long-term disease-free outcomes with acceptable morbidities among patients with IR PCa. In addition, the incidence of late recurrence was very low. Further investigation is warranted to confirm our findings.
Keyphrases
  • prostate cancer
  • radiation therapy
  • risk factors
  • free survival
  • rectal cancer
  • radical prostatectomy
  • lymph node
  • type diabetes
  • squamous cell carcinoma
  • bone marrow
  • radiation induced
  • adipose tissue
  • insulin resistance